Switch to
More onapp

Colinz Laboratories Ltd

COLINZ
Health CarePharmaceuticals
SmallcapWith a market cap of ₹10 cr, stock is ranked 3,610
High RiskStock is 3.25x as volatile as Nifty
41.751.90 (+4.77%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹10 cr, stock is ranked 3,610
High RiskStock is 3.25x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
31.68
PB RatioPB Ratio
1.36
Dividend YieldDiv. Yield
Sector PESector PE
33.51
Sector PBSector PB
4.10
Sector Div YldSctr Div Yld
0.94%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Colinz Laboratories Ltd is engaged in the manufacturing and marketing of pharmaceutical formulations.

Financial TrendFinancial statements 

20192020202120227.717.666.357.140.110.120.200.33
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings